The report TitledBrazil Pharmaceuticals Market Outlook to 2025 – By International and Domestic Companies, By Retail and Institutional Sales,  By Institutional Sales (Public, Private and Others), By Drug Type (Prescription, Over-The-Counter and Generics), By Generic Drug Type (Branded and Local), By Region (Southeast, South, Northeast, Midwest and North), By Therapeutic Areasby Ken Research suggested that the Brazil Pharmaceuticals Market has been increasing due to the increasing per capita health expenditure, growing number of Chronic diseases, increasing demand of generic drugs in the market coupled with new market opportunities for Domestic Manufacturers.

Brazil Pharmaceuticals Market Cover Page

Growing Government Initiatives: Government in Brazil promoted initiatives such as the Growth Acceleration Program and the Greater Brazil Plan that were introduced largely to increase domestic production of drugs in Brazil. Growth Acceleration Program is focused on modernizing public infrastructure, while the Greater Brazil Plan encourages local production of innovative drugs and also promoting public – private partnerships in the form of technology transfer to other pharmaceutical laboratories for the development of higher-priced biosimilar drugs.

Growing Number of Substitutes for Patented Drugs: Generic Drugs alternatives are available for 95% of the treatments in Brazil. The local manufacturing companies on the other hand are largely involved in the manufacturing activities of the generic drugs and are now focusing on increasing their production targets of generics in different therapeutic areas so as to compete with patented drugs manufacturers in Brazil. Generic Drugs in the country are also becoming increasingly popular with prescription or in Over-The-Counter form, as consumers perception towards generic drugs to be taken as equivalent to the branded medications is also growing.

Growing Number of Mergers and Acquisitions: Growing ageing population of Brazil and increase in demand for generic and other medicines has led major players in the industry to expand in terms of their production capabilities. So as to capture the potential areas, the industry has witnessed various mergers and acquisitions over the last few years. The companies have majorly focused on acquiring smaller companies or brands in order to expand their product portfolio or add a new business segment.

The market is expected to register a positive CAGR of 8.4% in terms of revenue during the forecast period 2018-2025.

Key Segments Covered

By Type of Companies

International Companies

Domestic Companies

By Type of Channel

Institutional

Public

Private

Others

Retail

By Drug Type

Prescription

Over-The-Counter

Generics

Branded

Local

By Region

Southeast

South

Midwest

Northeast

North

By Therapeutic Areas

Cardiovascular

Central Nervous System

Respiratory

Oncology

Anti-Infective

Gastrointestinal

Others

Key Target Audience

Pharmaceutical Manufacturing Companies

Pharmacy Retail Outlets

Government/ Regulatory Authorities

Venture Capitalist Firms

Health Insurance Companies

Pharmaceutical Products Distributors

Time Period Captured in the Report:

Historical Period: 2013-2018

Forecast Period: 2019F-2025F

Companies Covered:

Major Manufacturers

Ache Laboratories

EMS Pharma

Eurofarma

Sanofi

Novartis

Neo Quimica

Mantecopr Farmasa

Libbs

Biolab- Sanus Farma

Takeda Pharma

Medley

Bayer Pharma

CIMED

Pfizer

GSK Pharma

FQM Grupo

Hypera Ch

Abbott Laboratories

Janssen Pharmaceuticals

Key Topics Covered in the Report

Brazil Pharmaceuticals Market Overview and Genesis (Overview and Genesis, Business Cycle Graph)

Brazil Pharmaceutical Market Value Chain Analysis

Brazil Pharmaceutical Market Size

Brazil Pharmaceuticals Market Segmentation

Regulatory Landscape in Brazil Pharmaceuticals Market

Trends and Developments in Brazil Pharmaceuticals Market

Issues and Challenges in Brazil Pharmaceuticals Market

Brazil Pharmaceuticals Market Competition Landscape

Cross Comparison of 7 Major Players in Brazil Pharmaceuticals Market

Brazil Pharmaceuticals Market Future Projection, 2018-2025F

Future Outlook of Brazil Pharmaceuticals Market Segmentations, 2018-2025F

Analyst Recommendations

For more information, refer to below link:

Brazil Pharmaceuticals Market

Related Reports

APAC Healthcare AI Market Outlook to 2025 – By Applications (Machine/Robot Assisted Medical Procedures, Clinical Trial & Drug Discovery/Development, Preliminary Diagnosis, Administrative Workflow Assistance, Virtual Nursing Assistant, Fraud Detection, Dosage Error Reduction), by Countries, by End Users & by Technologies and Current Investment Scenario

India Medical Device Market Outlook to 2023 – by IVD Market (Type of Device, Sales Channel, Domestic Manufacturing and Import), by Diagnostic Imaging Market (Type of Device, Domestic Manufacturing and Import) and by Patient Aid Market (Orthopedic Device, Hospital Furniture and Hearing Aid)

Global Hearing Aid Market Outlook to 2023 – By Hearing Aid Devices (By Ear and By Canal) and Hearing Implants (Cochlear implants and BAHA implants), By Region (Americas, Europe, Asia-Pacific and RoW), By Type of Distribution channel (Audiology & ENT clinics, Hospitals and Pharmacies)

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249